[go: up one dir, main page]

AU2001276022A1 - Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4 - Google Patents

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4

Info

Publication number
AU2001276022A1
AU2001276022A1 AU2001276022A AU7602201A AU2001276022A1 AU 2001276022 A1 AU2001276022 A1 AU 2001276022A1 AU 2001276022 A AU2001276022 A AU 2001276022A AU 7602201 A AU7602201 A AU 7602201A AU 2001276022 A1 AU2001276022 A1 AU 2001276022A1
Authority
AU
Australia
Prior art keywords
vla
inhibitors
beta
amino acid
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276022A
Inventor
Susan Ashwell
Darren B. Dressen
Francine S. Grant
Andrei W. Konradi
Anthony Kreft
Michael A Pleiss
Dimitrios Sarantakis
Christopher Semko
Frank Stappenbeck
Eugene D. Thorsett
Gregory S. Welmaker
Ying-Zi Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Elan Pharmaceuticals LLC
Original Assignee
Elan Pharmaceuticals LLC
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22822136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001276022(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elan Pharmaceuticals LLC, American Home Products Corp filed Critical Elan Pharmaceuticals LLC
Publication of AU2001276022A1 publication Critical patent/AU2001276022A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001276022A 2000-07-21 2001-07-20 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4 Abandoned AU2001276022A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22011800P 2000-07-21 2000-07-21
US60220118 2000-07-21
PCT/US2001/023071 WO2002008201A2 (en) 2000-07-21 2001-07-20 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4

Publications (1)

Publication Number Publication Date
AU2001276022A1 true AU2001276022A1 (en) 2002-02-05

Family

ID=22822136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276022A Abandoned AU2001276022A1 (en) 2000-07-21 2001-07-20 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4

Country Status (4)

Country Link
US (2) US6953802B2 (en)
AU (1) AU2001276022A1 (en)
PE (1) PE20020384A1 (en)
WO (1) WO2002008201A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI281470B (en) * 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
WO2005000244A2 (en) * 2003-06-25 2005-01-06 Elan Pharmaceuticals, Inc. Methods and compositions for treating rheumatoid arthritis
ATE405553T1 (en) * 2004-12-08 2008-09-15 Bristol Myers Squibb Co HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA
MY151045A (en) 2006-02-27 2014-03-31 Elan Pharm Inc Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
US20080319652A1 (en) * 2007-06-20 2008-12-25 Radiofy Llc Navigation system and methods for map navigation
WO2011020874A1 (en) 2009-08-20 2011-02-24 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
AR081626A1 (en) 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
PL3873605T3 (en) 2018-10-30 2025-03-03 Gilead Sciences, Inc. Compounds for inhibition of alpha4beta7 integrin
DK3873884T3 (en) 2018-10-30 2025-02-17 Gilead Sciences Inc 3-(QUINOLIN-8-YL)-1,4-DIHYDROPYRIDO[3,4-D]PYRIMIDINE-2,4-DIONE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
EP3873897B1 (en) 2018-10-30 2024-08-14 Gilead Sciences, Inc. N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases
US11578069B2 (en) 2019-08-14 2023-02-14 Gilead Sciences, Inc. Compounds for inhibition of α4 β7 integrin
US20240301512A1 (en) 2021-01-29 2024-09-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330506A3 (en) 1988-02-26 1990-06-20 Dana Farber Cancer Institute Vla proteins
US5510332A (en) 1994-07-07 1996-04-23 Texas Biotechnology Corporation Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
DE69530392D1 (en) 1994-07-11 2003-05-22 Athena Neurosciences Inc INHIBITORS OF LEUKOCYTE ADHESION

Also Published As

Publication number Publication date
US6953802B2 (en) 2005-10-11
US7223762B2 (en) 2007-05-29
WO2002008201A3 (en) 2002-06-27
US20020058664A1 (en) 2002-05-16
PE20020384A1 (en) 2002-05-28
US20050192280A1 (en) 2005-09-01
WO2002008201A2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2623900A (en) Compounds which inhibit leukocyte adhesion mediated by vla-4
AU2001276022A1 (en) Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4
AU2003229033A1 (en) Acrylic structural adhesive having improved t-peel strength
AU2002243328A1 (en) Modified rubber-based adhesives
AU2003256329A1 (en) Use of adhesion molecules as bond stress-enhanced nanoscale binding switches
AU2003265235A1 (en) Non-affinity purification of proteins
AU2003223188A1 (en) Adhesives
IL133641A0 (en) Compounds which inhibit leukocyte adhesion mediated by vla-4
AU2003206689A1 (en) Radiation-hardened coatings with improved adhesive strength
AU3348800A (en) Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
AU2002307432A1 (en) Production of alpha-lipoic acid
IL165077A0 (en) Inectable solid hyaluronic acid carriers for delivery of osteogenic proteins
AU2001282938A1 (en) Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by vla-4
AU2001268701A1 (en) Methods of enhancing adhesion
AU2001288086A1 (en) Vulcanizable adhesive composition
AU2623800A (en) Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
AU4810600A (en) Method of inhibiting leukocyte adhesion to fibrinogen
EP1369479A4 (en) Novel cell adhesion molecule specific to activated leukocyte
AU2003251681A1 (en) Ghrelin binding nucleic acids
AU3348700A (en) Compounds which inhibit leukocyte adhesion mediated by vla-4
AU2003282162A1 (en) Novel adhesives comprising diacetals
AU2003265845A1 (en) METHODS FOR THE PREPARATION OF Beta-AMINO ACIDS
AU2003280382A1 (en) Enzymatic polymerisation of miniemulsions
AU2001249477A1 (en) Lactams as inhibitors of a-beta protein production
AU2003221056A1 (en) Novel promoters